Literature DB >> 7770748

Human rabies: a continuing challenge in the tropical world.

D A Warrell1, M J Warrell.   

Abstract

More than 99% of all human rabies deaths in the world occur in tropical developing countries. In India alone, 30,000 to 50,000 people may die of rabies each year. The Lyssaviruses (Family Rhabdoviridae) include rabies and rabies-related viruses, 3 of which have caused human disease. Rabies is a zoonosis, principally affecting domestic and stray dogs in most parts of Africa, Asia and Latin America. In North America, southern Africa, parts of the Caribbean and Europe, the principal mammalian reservoir species are wild carnivores. The pathogenesis, clinical features and differential diagnosis of rabies are discussed. The planning of rabies control strategies requires background information on the distribution and incidence of rabies in animals and the species involved. In some parts of the world, such as Latin American cities, most domestic dogs, even apparent strays, have an owner and can be immunized with conventional canine vaccines during well publicized campaigns. However, in areas such as India, where there may be a high proportion of stray domestic dogs without owners, and in those areas where wild mammals are the principal reservoir species, immunization may be possible using live attenuated or recombinant oral vaccines distributed in baits. In the poor tropical developing countries, unsatisfactory nervous tissue vaccines are still widely used. However, economical multisite intradermal regimens using tissue culture vaccines have proved effective and have begun to replace nervous tissue vaccines in some countries.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770748

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  7 in total

1.  Dog bites in Bosnia.

Authors:  A Croft; R Archer
Journal:  Br J Gen Pract       Date:  1997-07       Impact factor: 5.386

2.  Retrospective analysis of suspected rabies cases reported at bugando referral hospital, mwanza, Tanzania.

Authors:  Humphrey D Mazigo; Fredros O Okumu; Eliningaya J Kweka; Ladslaus L Mnyone
Journal:  J Glob Infect Dis       Date:  2010-09

3.  Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein.

Authors:  Shukra M Aavula; Sridevi V Nimmagadda; Neelakantam Biradhar; Samuel Sula; Dev Chandran; Rajendra Lingala; Srinivasan Alwar Villuppanoor
Journal:  Biotechnol Res Int       Date:  2011-10-05

4.  Rabies Vaccination in a Pediatric Patient with Acute Myeloid Leukemia during the Course of Chemotherapy: a Case report.

Authors:  Viroj Wiwanitkit
Journal:  Iran J Cancer Prev       Date:  2014

5.  Human benefits of animal interventions for zoonosis control.

Authors:  Jakob Zinsstag; Esther Schelling; Felix Roth; Bassirou Bonfoh; Don de Savigny; Marcel Tanner
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

6.  One in a million, or one in thousand: What is the morbidity of rabies in India?

Authors:  Janie M Baxter
Journal:  J Glob Health       Date:  2012-06       Impact factor: 4.413

7.  Geographical and temporal patterns of rabies post exposure prophylaxis (PEP) incidence in humans in the Mekong River Delta and Southeast Central Coast regions in Vietnam from 2005 to 2015.

Authors:  Hu Suk Lee; Vu Dinh Thiem; Dang Duc Anh; Tran Nhu Duong; Mihye Lee; Delia Grace; Hung Nguyen-Viet
Journal:  PLoS One       Date:  2018-04-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.